WILSON’S DISEASE TREATMENT MARKET ANALYSIS

Wilson’s Disease Treatment Market, by Treatment Medications (D-Penicillamine, Trientine, Zinc, Tetrathiomolybdate), Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Government bodies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jun 2022
Code : CMI526
Pages :185
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Lack of awareness of Wilson’s disease
Lack of diagnosis facilities for Wilson’s disease

Global Wilson’s disease Treatment Market: Restraint

The major factors that hinder growth of the global Wilson’s disease treatment market include lack of awareness and diagnosis facilities associated with Wilson’s disease treatment. For instance, according to data published by National Center for Biotechnology Information (NCBI) in April 2019, Wilson’s disease is rare autosomal recessive disorder and has stated that no single examination can unequivocally confirm or exclude the disease. Diagnosis of patients with Wilson’s disease is challenging as it is based on a complex set of clinical findings that are derived from physical examination, patient history as well as imaging testing and pathology laboratory with adequate facilities. The lack of all the mentioned facilities had made it difficult to collect the data and estimate about the diagnosis data about patients suffering with Wilson’s disease.